Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Hepatocellular carcinoma can still occur after hepatitis C is cured, and risk factors differ for people with and without cirrhosis.
The number of people treated for hepatitis C hit a low point during the COVID-19 pandemic.
People treated with direct-acting antivirals had better overall survival than those whose hepatitis C remained untreated.
Despite limited testing and clinical visits, 95% of the study population was able to achieve a sustained virological response.
Hepatitis A and E usually resolve on their own, but hepatitis B and C can cause serious liver disease, including cirrhosis and liver cancer.
Requiring sobriety prior to treatment and curtailing harm reduction hinder efforts to eliminate hep C.
The blood-borne virus, which can lead to cirrhosis and liver cancer, remains a major global health threat.
Homeless people, incarcerated individuals and people with mental health conditions achieved a high cure rate.
All people ages 18 to 79 should be screened for hepatitis C virus at least once, regardless of risk factors.
Study results underline the importance of treating hepatitis C virus.
Successful treatment with direct-acting antivirals prolonged survival by 18 months.
Those diagnosed with liver cancer after an HCV cure had a 66% lower risk of death.
Cure rates are high, but some young people already have advanced liver damage by the time they’re treated.
Researchers analyzed health data regarding modern hep C treatments specific to New South Wales.
Do you know your liver cancer risk?
The VA has cured HCV in nearly 100,000 veterans, which will dramatically reduce the development of advanced liver disease and liver cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.